Skip to content
healthcare.dev

Meclizine HCL

NDC 54738-025, Meclizine HCl 25mg Chewable Tablets, tablet, chewable, from Richmond Pharmaceuticals, Inc..

Product NDC
54738-025
Status
Listed
Labeler
Richmond Pharmaceuticals, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
part336
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54738-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MECLIZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Antiemetic [EPC]; Emesis Suppression [PE]

Package NDCNDC-11Package
54738-025-0154738002501100 TABLET, CHEWABLE in 1 BOTTLE (54738-025-01)
54738-025-03547380025031000 TABLET, CHEWABLE in 1 BOTTLE (54738-025-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 54738-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54738-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54738-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.